Liu Min, Ma Zhanhong, Guo Xiaojuan, Zhu Jianguo, Su Jun
Department of Radiology, Imaging Center, Chao Yang Hospital of Capital Medical University, Beijing, China.
Clin Physiol Funct Imaging. 2012 Jan;32(1):25-32. doi: 10.1111/j.1475-097X.2011.01050.x. Epub 2011 Sep 29.
The assessment of myocardial viability has become an important aspect of the diagnostic and prognostic work-up of patients with coronary artery disease. Technetium-99m labelled sestamibi ((99m)Tc-MIBI) myocardial perfusion imaging may underestimate the viability of ischaemic myocardium. Technetium-99m labelled 4,9-diaza-3,3,10,10-tetramethyldodecan-2,11-dione dioxime ((99m)Tc-HL91) is a hypoxia-avid agent which can identify acutely ischaemic viable myocardium in a canine model using a standard gamma camera. The aim of this study was to evaluate uptake character of ischaemic viable myocardium and diagnostic performance of single-photon emission computed tomography (SPECT) imaging by (99m)Tc-HL91 and (99m)Tc-MIBI in detecting ischaemic viable myocardium in coronary heart disease.
A total of 41 patients with coronary artery disease were recruited from March 2008 to May 2009. For detecting ischaemic viable myocardium, SPECT imaging by (99m)Tc-HL91 and (99m)Tc-MIBI were performed in all patients before coronary revascularization. Six patients with single ischaemic myocardial segment received a 2-day SEPCT/CT imaging protocol and the uptake of (99m)Tc-HL91 in ischaemic myocardium was quantitatively analysed. The remaining 35 patients received a 1-day (99m)Tc-HL91 and (99m)Tc-MIBI SPECT imaging protocol. Resting (99m)Tc-MIBI myocardial perfusion imaging in 3-18 months after revascularization was used as the standard methodology to evaluate the myocardial viability.
In 41 patients, 66 ischaemic myocardial segments were proven to be viable and 12 to be necrotic by resting (99m)Tc-MIBI myocardial perfusion imaging after coronary revascularization. Furthermore, 60 viable segments with negative uptake of (99m)Tc-MIBI showed positive uptake of (99m)Tc-HL91. The remaining six viable segments and 12 necrotic segments showed both negative uptake of (99m)Tc-HL91 and (99m)Tc-MIBI. The sensitivity, specificity, accuracy, Younden Index, positive predictive value and negative predictive value for evaluating ischaemic viable myocardium were 90·9%, 100%, 92·3%, 90·9%, 100% and 66·7%, respectively. Ischaemic viable myocardium had the negative (99m)Tc-MIBI uptake and positive (99m)Tc-HL91 uptake, which demonstrated a mismatched uptake character. Quantitative analysis indicated the uptake of (99m)Tc-HL91 in viable myocardium was increasing in the first 1-3 h and remained stable at the 3-4 h after injection.
Functional SPECT imaging with (99m)Tc-HL91 and (99m)Tc-MIBI can be used to detect the seriously ischaemic but viable myocardium with a mismatched uptake character. The uptake of (99m)Tc-HL91 in the viable myocardium reached a stable level at 3-4 h after injection.
心肌存活评估已成为冠心病患者诊断和预后检查的重要方面。锝-99m标记的甲氧基异丁基异腈((99m)Tc-MIBI)心肌灌注显像可能会低估缺血心肌的存活情况。锝-99m标记的4,9-二氮杂-3,3,10,10-四甲基十二烷-2,11-二酮二肟((99m)Tc-HL91)是一种对缺氧有亲和力的药物,它可以使用标准伽马相机在犬模型中识别急性缺血存活心肌。本研究的目的是评估缺血存活心肌的摄取特征以及单光子发射计算机断层扫描(SPECT)成像通过(99m)Tc-HL91和(99m)Tc-MIBI检测冠心病缺血存活心肌的诊断性能。
2008年3月至2009年5月共招募了41例冠心病患者。为检测缺血存活心肌,所有患者在冠状动脉血运重建前均进行了(99m)Tc-HL91和(99m)Tc-MIBI的SPECT成像。6例单缺血心肌节段患者接受了为期2天的SEPCT/CT成像方案,并对缺血心肌中(99m)Tc-HL91的摄取进行了定量分析。其余35例患者接受了为期1天的(99m)Tc-HL91和(99m)Tc-MIBI SPECT成像方案。血运重建后3至18个月的静息(99m)Tc-MIBI心肌灌注显像被用作评估心肌存活的标准方法。
在41例患者中,冠状动脉血运重建后经静息(99m)Tc-MIBI心肌灌注显像证实66个缺血心肌节段存活,12个坏死。此外(99m)Tc-MIBI摄取阴性的60个存活节段显示(99m)Tc-HL91摄取阳性。其余6个存活节段和12个坏死节段显示(99m)Tc-HL91和(99m)Tc-MIBI摄取均为阴性。评估缺血存活心肌的敏感性、特异性、准确性、约登指数、阳性预测值和阴性预测值分别为90.9%、100%、92.3%、90.9%、100%和66.7%。缺血存活心肌具有(99m)Tc-MIBI摄取阴性和(99m)Tc-HL91摄取阳性的特征,表现为摄取不匹配。定量分析表明,存活心肌中(99m)Tc-HL91的摄取在注射后1至3小时内增加,并在3至4小时保持稳定。
(99m)Tc-HL91和(99m)Tc-MIBI的功能性SPECT成像可用于检测具有摄取不匹配特征的严重缺血但存活的心肌。存活心肌中(99m)Tc-HL91的摄取在注射后3至4小时达到稳定水平。